As a long term holder with no immediate interest in selling or needing the funds etc etc, from a shareholder perspective I'm frustrated by the US relocation despite mostly agreeing that it will be worthwhile for IHL as a pre-clinical growth stage company.
The nuisance of setting up international trading portfolio in addition to what I'm sure will be annoying tax implications has me irked, personally.
I'd be lying if I said I'm not giving serious thought to offloading it all with a small profit. GLTAH.
IHL Price at posting:
8.4¢ Sentiment: Hold Disclosure: Held
